| [1] |
Yoko S, Kobayashi Y, Iiri T, et al. Pacing lead-induced granuloma in the atrium: a foreign body reaction to polyurethane[J]. Case Rep Cardiol, 2013:396595.
|
| [2] |
Esposito M, Kennergren C, Holmström N, et al. Morphologic and immunohistochemical observations of tissues surrounding retrieved transvenous pacemaker leads[J]. J Biomed Mater Res, 2002,63(5):548-558.
|
| [3] |
Novak M, Dvorak P, Kamaryt P, et al. Autopsy and clinical context in deceased patients with implanted pacemakers and defibrillators: intracardiac findings near their leads and electrodes[J]. Europace, 2009,11(11):1510-1516.
|
| [4] |
Segreti L, Di Cori A, Soldati E, et al. Major predictors of fibrous adherences in transvenous implantable cardioverter-defibrillator lead extraction[J]. Heart Rhythm, 2014,11(12):2196-2201.
|
| [5] |
李延辉, Dykoski Richard, 李剑明. 经静脉置入起搏/除颤导线引起的心脏血管慢性病理改变[J].中华心血管病杂志,2015,43(5):423-427.
|
| [6] |
Keiler J, Schulze M, Dreger R, et al. Quantitative and qualitative assessment of adhesive thrombo-fibrotic lead encapsulations (TFLE) of pacemaker and ICD leads in arrhythmia patients-a post mortem study[J]. Front Cardiovasc Med, 2020,7:602179.
|
| [7] |
Epstein AE, Kay GN, Plumb VJ, et al. Gross and microscopic pathological changes associated with nonthoracotomy implantable defibrillator leads[J]. Circulation, 1998,98(15):1517-1524.
|
| [8] |
Li JM, Li Y, Tholakanahalli V, et al. Fibrous encapsulation of defibrillation electrode and elevated high-voltage impedance in patients with a subcutaneous implantable cardioverter-defibrillator[J]. HeartRhythm Case Rep, 2019,6(3):148-152.
|
| [9] |
Frutos Perez JM, Llopis Sanchis M, Moreno Torres B, et al. Sudden death due to thrombosis associated with implantable cardioverter-defibrillator electrodes[J]. Eur J Case Rep Intern Med, 2021,8(3):002247.
|
| [10] |
Singer I, Hutchins GM, Mirowski M, et al. Pathologic findings related to the lead system and repeated defibrillations in patients with the automatic implantable cardioverter-defibrillator[J]. J Am Coll Cardiol, 1987,10(2):382-388.
|
| [11] |
李延辉, 李剑明. 激光导管拔除心脏起搏除颤导线的临床应用研究[J]. 中华心血管病杂志,2011,39(4):363-368.
|
| [12] |
Zhou X, Ze F, Li D, et al. Outcomes of transvenous lead extraction in patients with lead perforation: a single-center experience[J]. Clin Cardiol, 2020,43(4):386-393.
|
| [13] |
Van Rooden CJ, Molhoek SG, Rosendaal FR, et al. Incidence and risk factors of early venous thrombosis associated with permanent pacemaker leads[J]. J Cardiovasc Electrophysiol, 2004,15:1258-1262.
|
| [14] |
Zimetbaum P, Carroll BJ, Locke AH, et al. Lead-related venous obstruction in patients with implanted cardiac devices: JACC Review Topic of the Week[J]. J Am Coll Cardiol, 2022,79(3):299-308.
|
| [15] |
Dokainish H, Elbarasi E, Masiero S, et al. Prospective study of tricuspid valve regurgitation associated with permanent leads in patients undergoing cardiac rhythm device implantation: Background, rationale, and design[J]. Glob Cardiol Sci Pract, 2015,2015(3):41.
|
| [16] |
Addetia K, Harb SC, Hahn RT, et al. Cardiac Implantable electronic device lead-induced tricuspid regurgitation[J]. JACC Cardiovasc Imaging, 2019,12(4):622-636.
|
| [17] |
Rajappan K. Permanent pacemaker implantation technique: part II[J]. Heart, 2009,95(4):334-342.
|
| [18] |
Noheria A, Ponamgi SP, Desimone CV, et al. Pulmonary embolism in patients with transvenous cardiac implantable electronic device leads[J]. Europace, 2016,18(2):246-252.
|